Ares Commercial Real Estate Co. (NYSE:ACRE – Get Free Report) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 2,500,000 shares, an increase of 7.8% from the May 15th total of 2,320,000 shares. Based on an average trading volume of 580,500 shares, the short-interest ratio is currently 4.3 days.
Wall Street Analyst Weigh In
Several research firms have weighed in on ACRE. StockNews.com cut Ares Commercial Real Estate from a “hold” rating to a “sell” rating in a research report on Monday, May 27th. Keefe, Bruyette & Woods decreased their price target on Ares Commercial Real Estate from $7.50 to $7.00 and set a “market perform” rating on the stock in a research report on Friday, May 10th. Bank of America reaffirmed an “underperform” rating and issued a $7.00 price objective (down from $11.00) on shares of Ares Commercial Real Estate in a research note on Monday, March 4th. JPMorgan Chase & Co. cut their price target on Ares Commercial Real Estate from $8.00 to $7.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th. Finally, TheStreet lowered Ares Commercial Real Estate from a “c-” rating to a “d+” rating in a research note on Tuesday, March 5th. Two analysts have rated the stock with a sell rating and six have given a hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $8.42.
View Our Latest Stock Analysis on Ares Commercial Real Estate
Ares Commercial Real Estate Trading Down 1.0 %
Ares Commercial Real Estate (NYSE:ACRE – Get Free Report) last released its quarterly earnings data on Thursday, May 9th. The real estate investment trust reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.34). The firm had revenue of $18.69 million for the quarter, compared to the consensus estimate of $43.77 million. Ares Commercial Real Estate had a negative net margin of 54.60% and a positive return on equity of 0.84%. During the same quarter in the prior year, the firm earned $0.26 EPS. Research analysts forecast that Ares Commercial Real Estate will post -2.4 earnings per share for the current year.
Ares Commercial Real Estate Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 16th. Shareholders of record on Friday, June 28th will be given a $0.25 dividend. The ex-dividend date is Friday, June 28th. This represents a $1.00 annualized dividend and a yield of 13.99%. Ares Commercial Real Estate’s dividend payout ratio is currently -120.48%.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. GAMMA Investing LLC purchased a new position in shares of Ares Commercial Real Estate during the 4th quarter valued at $29,000. EntryPoint Capital LLC bought a new position in Ares Commercial Real Estate in the 1st quarter worth about $84,000. Virtu Financial LLC bought a new position in Ares Commercial Real Estate in the 1st quarter worth about $108,000. Strategic Wealth Partners Ltd. purchased a new position in shares of Ares Commercial Real Estate in the 1st quarter worth about $134,000. Finally, Triumph Capital Management boosted its holdings in shares of Ares Commercial Real Estate by 15.0% in the 1st quarter. Triumph Capital Management now owns 20,178 shares of the real estate investment trust’s stock worth $146,000 after purchasing an additional 2,626 shares in the last quarter. Hedge funds and other institutional investors own 41.34% of the company’s stock.
Ares Commercial Real Estate Company Profile
Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt and preferred equity products, mezzanine loans, and other CRE investments, including commercial mortgage-backed securities.
Read More
- Five stocks we like better than Ares Commercial Real Estate
- Health Care Stocks Explained: Why You Might Want to Invest
- Alzheimer’s Drug Stocks: Investing in Eli Lilly, Biogen, Roche
- Compound Interest and Why It Matters When Investing
- Occidental Stock: Buffett’s 9-Day Buying Spree Lifts Stake to 29%
- How to Choose Top Rated Stocks
- 3M Stock: Invest Now for Unmatched Quality and Growth Potential
Receive News & Ratings for Ares Commercial Real Estate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ares Commercial Real Estate and related companies with MarketBeat.com's FREE daily email newsletter.